跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Respitapp - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Respitapp
Approved
STANDARD
Respitapp
Accord Bio Laboratories
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7eb928aaf3c23192
Company
Accord Bio Laboratories
Type
Standard
Approval Details
Approval Id
7eb928aaf3c23192
Drug Approval Philippines Name
Respitapp
Product Name
Respitapp
Registration Number
DR-XY41311
Brand Name
Respitapp
Generic Name
Brompheniramine Maleate + Phenylephrine Hydrochloride
Dosage Form
Syrup
Dosage Strength
4 mg/ 12.5 mg per mL
Manufacturer
Accord Bio Laboratories
Trader
Le Jumont Pharmaceuticals, Inc.
Issuance Date
28 June 2021
Expiry Date
10 October 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7eb928aaf3c23192
Type
Standard
Back to Philippines FDA Approvals